InvestorsHub Logo
Followers 5
Posts 498
Boards Moderated 0
Alias Born 10/12/2017

Re: sleekscape post# 34552

Wednesday, 05/01/2019 9:55:25 AM

Wednesday, May 01, 2019 9:55:25 AM

Post# of 61508
On this topic of FDA's view of CBD products in the marketplace, if anyone's interested, I found this blog post from a lawyer quite informative:

Link

"The FDA has taken a “not legal” position on hemp-CBD in consumables through its oft-cited FAQ and elsewhere. This FDA position is generally understood as “informal guidance” or a “statement of policy”, or sometimes a “nonlegislative rule” or an “interpretive rule”, which by any name does not have the force of law. FDA commonly issues informal guidance as its primary method of policy-making, which means that the agency does not undertake the Administrative Procedure Act (APA) process of “notice and comment” rulemaking in many cases. This has been FDA custom for a long time."

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BLEG News